7Baggers
 Orgenesis (NASDAQ:ORGS) and Oragenics (NYSE:OGEN) Critical Contrast  Defense World Tue, 30 Sep 2025 06:08:11 GMT
 published on: 2025-09-12 05:07:15  Newser Fri, 12 Sep 2025 10:07:15 GMT
 published on: 2025-09-12 01:31:29  Newser Fri, 12 Sep 2025 06:31:29 GMT
 published on: 2025-09-12 00:01:02  Newser Fri, 12 Sep 2025 05:01:02 GMT
 published on: 2025-09-11 20:13:02  Newser Fri, 12 Sep 2025 01:13:02 GMT
 published on: 2025-09-09 22:56:53  Newser Wed, 10 Sep 2025 03:56:53 GMT
 published on: 2025-09-09 01:14:20  Newser Tue, 09 Sep 2025 06:14:20 GMT
 published on: 2025-09-08 01:49:21  Newser Mon, 08 Sep 2025 06:49:21 GMT
 oragenics appoints natasha giordano to board of directors  The Globe and Mail Wed, 03 Sep 2025 21:34:00 GMT

Oragenics, Inc
(NYSE MKT:OGEN) 

OGEN stock logo

Oragenics, Inc. develops antibiotics for infectious diseases in the United States. Its lead product candidate under development is OG716, an antibiotic for the treatment of Clostridium difficile. The company also engages in the development and commercialization of Terra CoV-2, a vaccine product cand...

Founded: 1996
Full Time Employees: 7
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends